167 related articles for article (PubMed ID: 34425846)
1. Cardiac amyloidosis screening using a relative apical sparing pattern in patients with left ventricular hypertrophy.
Nakao Y; Saito M; Inoue K; Higaki R; Yokomoto Y; Ogimoto A; Suzuki M; Kawakami H; Hiasa G; Okayama H; Ikeda S; Yamaguchi O
Cardiovasc Ultrasound; 2021 Aug; 19(1):30. PubMed ID: 34425846
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis.
Cariou E; Bennani Smires Y; Victor G; Robin G; Ribes D; Pascal P; Petermann A; Fournier P; Faguer S; Roncalli J; Rousseau H; Chauveau D; Carrié D; Berry I; Galinier M; Lairez O;
Amyloid; 2017 Jun; 24(2):101-109. PubMed ID: 28553897
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy.
Melero Polo J; Roteta Unceta-Barrenechea A; Revilla Martí P; Pérez-Palacios R; Gracia Gutiérrez A; Bueno Juana E; Andrés Gracia A; Atienza Ayala S; Aibar Arregui MÁ
Cardiol J; 2023; 30(2):266-275. PubMed ID: 34355777
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative assessment of the relative apical sparing pattern of longitudinal strain for cardiac amyloidosis identification.
Saito M; Imai M; Wake D; Higaki R; Nakao Y; Sumimoto T; Yokomoto Y; Ogimoto A; Suzuki M; Kawakami H; Hiasa G; Okayama H; Inoue K; Ikeda S; Yamaguchi O
Echocardiography; 2020 Sep; 37(9):1422-1429. PubMed ID: 32860644
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
[TBL] [Abstract][Full Text] [Related]
6. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.
Phelan D; Collier P; Thavendiranathan P; Popović ZB; Hanna M; Plana JC; Marwick TH; Thomas JD
Heart; 2012 Oct; 98(19):1442-8. PubMed ID: 22865865
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic and clinical predictors of cardiac amyloidosis: limitations of apical sparing.
Kyrouac D; Schiffer W; Lennep B; Fergestrom N; Zhang KW; Gorcsan J; Lenihan DJ; Mitchell JD
ESC Heart Fail; 2022 Feb; 9(1):385-397. PubMed ID: 34877800
[TBL] [Abstract][Full Text] [Related]
8. Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography.
Ferkh A; Tjahjadi C; Stefani L; Geenty P; Byth K; De Silva K; Boyd AC; Richards D; Mollee P; Korczyk D; Taylor MS; Kwok F; Kizana E; Ng ACT; Thomas L
Front Cardiovasc Med; 2023; 10():1183485. PubMed ID: 37465456
[TBL] [Abstract][Full Text] [Related]
9. Phasic left atrial strain analysis to discriminate cardiac amyloidosis in patients with unclear thick heart pathology.
Brand A; Frumkin D; Hübscher A; Dreger H; Stangl K; Baldenhofer G; Knebel F
Eur Heart J Cardiovasc Imaging; 2021 May; 22(6):680-687. PubMed ID: 32243500
[TBL] [Abstract][Full Text] [Related]
10. Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study.
Cotella J; Randazzo M; Maurer MS; Helmke S; Scherrer-Crosbie M; Soltani M; Goyal A; Zareba K; Cheng R; Kirkpatrick JN; Yogeswaran V; Kitano T; Takeuchi M; Fernandes F; Hotta VT; Campos Vieira ML; Elissamburu P; Ronderos R; Prado A; Koutroumpakis E; Deswal A; Pursnani A; Sarswat N; Addetia K; Mor-Avi V; Asch FM; Slivnick JA; Lang RM
Eur Heart J Cardiovasc Imaging; 2024 May; 25(6):754-761. PubMed ID: 38243591
[TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis.
Boldrini M; Cappelli F; Chacko L; Restrepo-Cordoba MA; Lopez-Sainz A; Giannoni A; Aimo A; Baggiano A; Martinez-Naharro A; Whelan C; Quarta C; Passino C; Castiglione V; Chubuchnyi V; Spini V; Taddei C; Vergaro G; Petrie A; Ruiz-Guerrero L; Moñivas V; Mingo-Santos S; Mirelis JG; Dominguez F; Gonzalez-Lopez E; Perlini S; Pontone G; Gillmore J; Hawkins PN; Garcia-Pavia P; Emdin M; Fontana M
JACC Cardiovasc Imaging; 2020 Apr; 13(4):909-920. PubMed ID: 31864973
[TBL] [Abstract][Full Text] [Related]
13. Relative apical sparing obtained with speckle tracking echocardiography is not a sensitive parameter for diagnosing light-chain cardiac amyloidosis.
Huang PN; Liu YN; Cheng XQ; Liu HY; Zhang J; Li L; Sun J; Gao YP; Lu RR; Gao YP; Deng YB
Quant Imaging Med Surg; 2024 Mar; 14(3):2357-2369. PubMed ID: 38545064
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Kumamoto criteria for prediction of
Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy.
Liu D; Hu K; Niemann M; Herrmann S; Cikes M; Störk S; Gaudron PD; Knop S; Ertl G; Bijnens B; Weidemann F
Circ Cardiovasc Imaging; 2013 Nov; 6(6):1066-72. PubMed ID: 24100046
[TBL] [Abstract][Full Text] [Related]
16. A simple echocardiographic score to rule out cardiac amyloidosis.
Aimo A; Chubuchny V; Vergaro G; Barison A; Nicol M; Cohen-Solal A; Castiglione V; Spini V; Giannoni A; Petersen C; Taddei C; Pasanisi E; Chacko L; Martone R; Knight D; Brown J; Martinez-Naharro A; Passino C; Fontana M; Emdin M
Eur J Clin Invest; 2021 May; 51(5):e13449. PubMed ID: 33185887
[TBL] [Abstract][Full Text] [Related]
17. RWT/SaVR-A Simple and Highly Accurate Measure Screening for Transthyretin Cardiac Amyloidosis.
Arnberg E; Eldhagen P; Löfbacka V; Venkateshvaran A; Pilebro B; Lindqvist P
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887882
[TBL] [Abstract][Full Text] [Related]
18. Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
Nitsche C; Aschauer S; Kammerlander AA; Schneider M; Poschner T; Duca F; Binder C; Koschutnik M; Stiftinger J; Goliasch G; Siller-Matula J; Winter MP; Anvari-Pirsch A; Andreas M; Geppert A; Beitzke D; Loewe C; Hacker M; Agis H; Kain R; Lang I; Bonderman D; Hengstenberg C; Mascherbauer J
Eur J Heart Fail; 2020 Oct; 22(10):1852-1862. PubMed ID: 32078212
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis.
Roslan A; Kamsani SH; Nay TW; Tan KL; Hakim N; Tan AM; Megat Samsudim WN; Tan KL; Jauhari AT; Krishnan M; Leong D; Supramaniam T; Tan LK; Nuruddin AA
Med J Malaysia; 2018 Dec; 73(6):388-392. PubMed ID: 30647209
[TBL] [Abstract][Full Text] [Related]
20. Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
Yamamura S; Izumiya Y; Ishida T; Onoue Y; Kimura Y; Hanatani S; Araki S; Fujisue K; Sueta D; Kanazawa H; Takashio S; Usuku H; Sugamura K; Sakamoto K; Yamamoto E; Yamamuro M; Yasuda H; Kojima S; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
Heart Vessels; 2017 Jun; 32(6):708-713. PubMed ID: 27882404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
